Abstract
NXL104 potentiates ceftazidime and ceftaroline against Enterobacteriaceae with extended-spectrum, AmpC, KPC and OXA β-lactamases. We examined whether similar potentiation was obtained against non-fermenters, which are less permeable than Enterobacteriaceae and have more potent efflux.
| Original language | English |
|---|---|
| Pages (from-to) | 2376-81 |
| Number of pages | 6 |
| Journal | Journal of Antimicrobial Chemotherapy |
| Volume | 65 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2010 |
Keywords
- Acinetobacter baumannii
- Anti-Bacterial Agents
- Azabicyclo Compounds
- Burkholderia cepacia complex
- Ceftazidime
- Drug Synergism
- Humans
- Microbial Sensitivity Tests
- Pseudomonas aeruginosa
- beta-Lactamases